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INTRODUCTION
It is well known that the success rate for traditional trabe-
culectomy is much lower in patients with intractable glau-
coma resulting from iris neovascularization or uveitis, or in
patients with profuse subconjunctival fibrosis due to any pre-
vious ocular procedure including filtering surgery (1). In these
patients, aqueous drainage devices have come into use to pre-
serve the visual function and to relieve pain caused by high
intraocular pressure (2). Among several devices in use, Ahmed
glaucoma valve implant has become one of the most popu-
lar devices because it lowers intraocular pressure satisfactori-
ly with low incidence of postoperative hypotony. But the ex-
posure of the some parts of the valve is noted occasionally and
bullous changes of corneal epithelium can occur infrequent-
ly due to the dysfunction of endothelial cells with the most
troublesome symptoms being decreased vision and severe ocu-
lar pain. 
In an effort to decrease incidence of implant exposure and
to alleviate ocular pain, we utilized amniotic membrane over
the tubal portion of the valve during Ahmed valve implanta-
tion and placed an amniotic membrane graft over the cornea.
The purpose of our study is to investigate if these new ap-
plications of amniotic membrane used in conjunction with
Ahmed valve implantation can be useful in stabilizing ocu-
lar surface and in lowering postoperative complications, thus
relieve severe ocular pain in the long run.
MATERIALS AND METHODS
We retrospectively reviewed the medical records of sixteen
patients with sixteen eyes who were followed in our clinic
from February 2002 to March 2004. Of sixteen patients, ten
patients were male and six were female. The mean age was
66.1±4.3 yr, two patients had the history of detachment of
retina, two had experienced trauma, five were pseudophakic,
two were aphakic, and one had received both penetrating ker-
atoplasty and intraocular lens insertion. The mean of intraoc-
ular pressure checked before the operation was 43.9±9.0
mmHg. They had undergone Ahmed valve insertion with
folded amniotic patch over the implant, and debridement of
corneal epithelium combined with amniotic membrane graft
over the exposed stroma for the control of the intractable glau-
coma with bullous keratopathy. With informed consent and
approval by the Institutional Review Board, human placenta
was obtained shortly after Cesarean delivery. The amniotic
membrane was harvested and preserved using the method
described by Kim and Tseng (3).
The drainage device used in this study was Ahmed type.
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A Novel Application of Amniotic Membrane in Patients with Bullous
Keratopathy
To evaluate the efficacy of amniotic membrane in the management of painful bullous
keratopathy secondary to the intractable glaucoma and in preventing exposure of
drainage devices, we inserted Ahmed valve with amniotic membrane patch graft
over the implant itself, and debrided corneal epithelium with amniotic membrane graft
over the exposed stroma as a single operation. During the follow-up periods, we
monitored vision, intraocular pressure (IOP), presence of ocular pain, and postop-
erative complications associated with the implants. The mean follow up period
was 8.4±3.2 months. IOP was well controlled after the intervention. The preopera-
tive mean IOP was measured as 43.9±9.0 mmHg and lowered to 16.1±1.8
mmHg at the last visit and no complications associated with the implants were
noted. Even though the improvement in vision was not prominent, the ocular sur-
face stabilized rapidly and ocular pain associated with bullous keratopathy disap-
peared soon after surgery. Conclusively the use of amniotic membrane in conjunc-
tion with Ahmed valve implantation is an effective way to relieve ocular pain and
lessen the chances of complications associated with the implant in patients with
intractable glaucoma and bullous keratopathy.
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This pear shaped polypropylene device was implanted into
eyes under retrobulbar anesthesia. All procedures were per-
formed by one surgeon. First, a fornix based conjunctival flap
was created in superior-temporal quadrant. Tenon’s capsule
was incised and the tissue was dissected off the sclera to cre-
ate a pocket for the plate of the valve. Care was taken to avoid
injury to any adjacent extraocular muscles. The tube was irri-
gated with balanced salt solution to ascertain that the valve
functions normally. The body plate of the implant was insert-
ed into the pocket. It was placed 8-9 mm posterior to the
corneal limbus and secured to the sclera with 10-0 nylon. The
anterior chamber was entered parallel to the iris plane just
posterior to the limbus using 23G needle. The tube was trim-
med so that the cut bevel faced the corneal endothelial sur-
face and was inserted into the anterior chamber along the pre-
viously created needle track, making sure the cut edge does
not extend over 2 mm from the entry site. The remaining
portion of tube was overlaid with amniotic membrane patch
graft. The amniotic membrane was cut into 6×18 mm rect-
angular piece and folded in half so that stromal surfaces face
each other, and then the membrane was secured to the sclera
using 10-0 nylon interrupted suture. The conjunctiva and
Tenon’s flaps were sutured back to the limbus. The bullous
corneal epithelium was scraped off mechanically using micro-
surgical sponge, fine forceps, and Beaver blade. Peripheral
corneal epithelium within 1 mm of limbus was not removed.
Then an amniotic membrane was cut into a disk shape and
was placed on the cornea with the stromal surface down. The
membrane was secured to the eye with 10-0 nylon in a con-
tinuous manner. Finally, we covered the whole surgical field
using a large amniotic membrane with amnion side down as
a temporal patch graft and secured it sclera with 10-0 nylon
interruptedly (Fig. 1). All the eyes received topical steroids
and antibiotics four times a day. At each follow up visit, visual
acuity, intraocular pressure, and postoperative conditions in-
cluding persistence of pain or occurrence of complications
were checked carefully.
RESULTS
The mean follow up period was 8.4±3.2 months. The
mean intraocular pressure (IOP) was significantly dropped
from 43.9±9.0 mmHg to 11.3±3.4 mmHg on the first
postoperative day and 16.1±1.8 mmHg at the last follow up
(p<0.01 by paired t-test). It was relatively well controlled
throughout the follow-up periods. Neither hypotony nor tran-
sient hypertensive period was noted. Vision was not improved
much except in one patient due to the severity of preexisting
pathologies. The corneal epithelium recovered well without
any bullae in all patients, and the averaged time elapsed for
the full reepithelialization of the cornea was 10.1±1.3 days.
We could not find any evidences of tubal exposure or erosion
of conjunctiva. The most notable finding was that the pain
vanished in all patients as the corneal surface became stabilized
rapidly with the use of amniotic membrane even in presence
of late partial dissolution of amniotic membrane and recurrent
bullae in some cases (Table 1). None of the patients experienced
severe ocular pain after surgery, and the IOP was significantly
lowered by the last follow up (p<0.01 by paired t-test).
The following three cases demonstrate well that our new
application of amniotic membrane during Ahmed valve im-
plantation reduced preoperative IOP and relieved pain signifi-
cantly without any serious complications.
Case 1
A 63-yr old man visited our clinic complaining of left ocu-
lar pain that had started 7 days before. He had lost his left
vision due to optic neuropathy after a traffic accident. He had
no light perception in that eye, and his IOP was measured as
high as 35 mmHg. On the slit lamp examination some corneal
opacities associated with epithelial bullae were noted, along
with intrastromal edema and neovascularization on corneal
surface. Surgery was performed as aforementioned method.
The IOP measured after surgery was 12 mmHg. Full reep-
ithelialization of cornea was achieved by the fifth postopera-
tive day. At his last visit IOP was well controlled at 18 mm
Hg, and no complications associated with the valve have
occurred. Cornea reepithelialized, and no bullae were found.
He has never experienced any ocular pain subsequently even
though focal melting of amniotic membrane developed (Fig.
2A, B).
Fig. 1. Sequential diagram of operative procedure. (A) Ahmed valve
was implanted and drainage tube is inserted into anterior chamber.
(B) Exposed tube was covered with amniotic membrane(AM) fold-
ed in half. (C) Cornea was covered with disc shaped AM graft with
stromal surface abutting cornea (arrow). (D) Finally, large tempo-
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Case 2
A 61-yr old man who had received cataract extraction sur-
gery 7 yr before, visited our clinic due to recurrent ocular pain
which has become increasingly more severe with time. He
could not perceive light and his IOP was 42 mmHg. The slit
lamp examination revealed a large bulla with opacity and stro-
mal edema in the inferior portion of cornea. He received the
same operation sequentially. The IOP after surgery was 15
mmHg. The full reepithelialization of cornea was achieved
by the sixth postoperative day. IOP was well controlled and
remained under 20 mmHg through his last visit and no com-
plications associated with the tube were noted. Cornea epithe-
lium looked stabilized. He did not complain of ocular pain
thereafter (Fig. 2 C, D).
Case 3
A 64 yr old woman who had received vitrectomy with sil-
icon oil replacement due to retinal hemorrhage and detach-
Sex/Age (yr) Etiology IOP2 V/A2 V/A1 Operation Pain after surgery IOP1 F/U
M/63 Trauma 10M 35 18 NLP NLP Ahmed, TAMG, PAMG  No (case 1)
M/61 Pseudophakia 16M 42 17 NLP NLP Ahmed, TAMG No (case 2)
F/64 RD 12M 35 18 NLP NLP Ahmed, TAMG, PAMG No (case 3)
F/70 Pseudophakia, NVG 10M 63 17 NLP NLP Ahmed, TAMG, PAMG No 
M/68 Pseudophakia, PKP 6M 38 14 NLP NLP Ahmed, TAMG, PAMG No 
F/71 Pseudophakia 7M 64 16 PLP 0.4 Ahmed, TAMG, PAMG No 
M/68 Aphakia 2M 40 13 FC10 0.04 Ahmed, TAMG, 2’ IOL No 
M/62 PKP 8M 40 13 HM 0.08 Ahmed, TAMG, PAMG No 
F/59 Trauma 6M 37 18 NLP NLP Ahmed, TAMG, PAMG No 
M/62 PKP 10M 41 16 HM FC20 Ahmed, TAMG, PAMG No 
F/57 RD 9M 38 16 NLP NLP Ahmed, TAMG, PAMG No 
M/65 Trauma 11M 48 17 NLP NLP Ahmed, TAMG, PAMG No 
F/61 Pseudophakia 8M 50 14 NLP NLP Ahmed, TAMG, PAMG No 
M/65 Pseudophakia 7M 39 15 NLP NLP Ahmed, TAMG, PAMG No 
M/71 Aphakia 8M 42 16 FC10 0.02 Ahmed, TAMG, PAMG, 2’ IOL No 
M/69 Pseudophakia 5M 51 19 NLP NLP Ahmed, TAMG, PAMG No
Table 1. Clinical characteristics and outcome
None of the patients experienced severe ocular pain after surgery, and the IOP2 was significantly lowered (p<0.01 by paired t-test). First five cases are
described in the text. F/U, follow-up period; IOP1, preoperative intraocular pressure; IOP2, intraocular pressure at the last follows up; V/A1, preoperative
visual acuity; V/A2, visual acuity at the last follows up; Ahmed, Ahmed valve implantation; TAMG, temporary amniotic membrane graft; PAMG, perma-
nent amniotic membrane graft; PLP, positive light perception; NLP, negative light perception; RD, retinal detachment; PKP, penetrating keratoplasty;
NVG, neovascular glaucoma; HM, hana motion; FC, finger count at a certain distance (cm); 2’10 L, secondary intraocular lens implantation.
Fig. 2. Biomicroscopic finding
of clinical cases. Case 1 (A)
Preoperative examination re-
veals corneal opacity, edema,
and bulla formation. (B) Exam-
ination 3 months after opera-
tion reveals that cornea is clear
and stable, and small focal melting of amniotic membrane is noted (arrow head). Case 2 (C) Preoperative finding reveals corneal edema
and large bulla formation (arrow). (D) Findings 4 months after operation reveals that cornea is well cleared. Case 3 (E) Total corneal opacity
with new vessels and bulla formation. (F) 4 months after operation, we can see well attached amniotic membrane and stabilized ocular
surface. (G) The Ahmed drainage tube is seen through the amniotic membrane graft. There is no evidence of complications associated
with drainage tube.
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ment 7 yr before, visited our clinic due to the severe right
ocular pain, which had developed 1 week ago. The slit lamp
examination revealed a number of bullae with almost total
corneal opacification and stromal edema. She could not per-
ceive light and her measured IOP was 35 mmHg. The sched-
uled operation was done as described before. The IOP mea-
sured after the surgery was 11 mmHg and was well controlled
measuring as low as 18 mmHg on her last visit after 10 mon-
ths postoperatively, and no complications associated with the
tube were found. The cornea epithelium was well established
and no bullae were found. The ocular pain disappeared after
that (Fig. 2E-G).
DISCUSSION
Since the drainage device was first used in 1912, various
kinds of devices have been developed (4-7). Ahmed valve
implant has many advantages over other devices owing to its
large drainage surface and less incidence of hypotony. But the
most common complication still not solved is the erosion of
conjunctiva that covers the implant and as a consequence, the
exposure of some parts of the implant itself (7, 8). Moreover
the exposure of implant tends to recur and can lead to secon-
dary bacterial infection, which can spread into intraocular
structure and can result in devastating endophthalmitis. In
such cases the implant has to be removed eventually. For this
reason, it is essential to carefully cover the tube and plate with
a graft during surgery. The graft used for this purpose should
be stable enough not to be absorbed easily and should not
impose any pressure on adjacent structures. Most common-
ly, a human donor scleral patch graft has been used to cover
the tubal portion of implant. However, even with the best
efforts, the exposure of the implant continues to occur, and
many other materials have been tried as a substitute for hu-
man donor scleral patch (9-12). Even though, some of these
materials are difficult to obtain, and there has been a concern
that human dura mata may transmit prion diseases such as
Creutzfeldt-Jakob. Therefore, there have been continued efforts
to find more suitable graft materials.
Bullous keratopathy are caused by the loss of endothelial
function and this in turn increases stromal hydration and
brings about loss of keratocytes, further hydration into intra-
epithelial space (13, 14). The patients may suffer from severe
ocular pain and decreased vision regardless what had initiat-
ed the insult to the cornea. Many modalities of the treatment
have been considered. In patients with reasonable vision poten-
tial, the treatment of choice is corneal transplantation. But
in patients with limited vision potential, the bandage contact
lens, anterior stromal puncture, annular keratotomy, thera-
peutic photorefractive keratectomy, or conjunctival flap can
be considered as a surgical option to relieve pain and to sup-
port corneal surface (15-18). Among these options, conjunc-
tival flap has a long history of wide use and is a well proven
and time-honored method for restoring ocular surface integrity
in diseased cornea. However poor cosmetic results and diffi-
culty in examining ocular pathology post-operatively have
been the major disadvantages of conjunctival flap. Recently
amniotic membrane was used to treat symptomatic bullous
keratopathy with excellent results (19).
Amniotic membrane is the innermost part of the placenta.
Since the study by Kim and Tseng on application of amniotic
membrane to rehabilitate severely damaged cornea in 1995,
its indications for use have been expanded rapidly (20-24).
Todays, the use of amniotic membrane as a carrier for epithe-
lial cells expansion is under investigation. The exact mecha-
nisms for how amniotic membrane induces favorable respons-
es in many diverse conditions are not fully understood, nor
are the membrane’s compositions. What is known about am-
niotic membrane so far is that it contains abundant extracel-
lular matrix materials such as fibronectin, laminin, type IV
collagen and integrin, as well as various protease and growth
factors. So amniotic membrane acts as a mechanical barrier
in many conditions in which ocular structural reinforcement
is needed, and thereby, it lessens ocular pain in exposed cornea
that has ocular surface pathology and offers substrate for epi-
thelial migration. By affecting down regulation of TGF-
system, amniotic membrane can also help corneal cells to dif-
ferentiate normally and retain their cellular characteristics and
thus prevent scar formation and maintains corneal clarity (25).
The protease inhibitors may play some roles in restoring nor-
mal ocular architecture (26). 
The advantages of amniotic membrane over other materi-
als are that it is easy to obtain, is relatively cheap, and is easy
to manipulate. Also it does not induce rejection. When need-
ed, the thickness of graft can be increased substantially by
folding the membrane. Moreover, since it is semi-translucent,
it renders cosmetically superb result and readily allows exam-
ination of the underlying structure, thus enabling early detec-
tion of any complications. 
With these backgrounds, we performed Ahmed valve inser-
tion with amniotic membrane patch graft over the implant
itself, and debridement of corneal epithelium with amniotic
membrane graft over the exposed stroma as a single operation
in patients with painful bullous keratopathy secondary to the
intractable glaucoma. The amniotic tissue transplanted over
the tube and plate portion of the implant remained intact
until the last follow-up and no complications associated with
the exposure of the implant were noted. After the implanta-
tion of drainage device, a transient rise of IOP is often seen
during the first 3 months postoperative period. This period
of transient rise in IOP is called hypertensive period (8). In
our study, however, we could not detect hypertensive phase
in any of the patients, and the IOP was well controlled through-
out the study. As the hypertensive period is thought to be
caused by the formation of fibrotic bleb around the implant,
the role of amniotic membrane in reducing fibrosis may play
some roles in preventing IOP rise. Our study showed excel-328 H.I. Lee, S.W. HA, J.C. Kim
lent results in the control of intraocular pressure: the mean
preoperative IOP was 43.9±9.0 mmHg and it dropped sig-
nificantly to 16.1±1.8 mmHg at the last visit. The IOP of
all patients were controlled within the desirable range until
the end of this study independent of the number of antiglau-
coma medication in use. These results were better in compari-
son with those reported in the earlier studies (8). And more-
over, none of the patients required secondary procedures such
as needling of bleb and injection of 5-fluorouracil to control
the IOP.
In the management of bullous keratopathy, amniotic mem-
brane is easy to manipulate during surgery does not impair
limbal cell function. Intolerable pain disappeared in all pa-
tients immediately after the procedure. And we experienced
prominent recovery of vision in one pseudophakic patient.
Her vision improved from light perception preoperatively to
0.4 at the last follow up. The translucency of the amniotic
membrane may play some roles in this improvement, thus
lessen the need of penetrating keratoplasty in the future. 
We noted partial dissolution of the amniotic membrane
and recurrence of small bullae in some patients, but none of
these patients reported any discomfort during the follow-up
periods. It is not easily explained how the relief of ocular pain
was maintained in such cases. As the mean follow up period
was relatively short, we have to investigate further in what
ways amniotic membrane have contributed in this regards. 
In summary, amniotic membrane transplantation is effec-
tive way to provide support for Ahmed valve and is an effica-
cious treatment for bullous keratopathy as it stabilizes ocular
surface rapidly.
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